PROSTest: Clinical Trials

3 trials of PROSTest, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow PROSTest: new trials by email Literature Review of PROSTest trials Research Report on PROSTest

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
Bicalutamide, Prostate-specific membrane antigen Positron Emission Tomography-Computed Tomography, 18F-rhPSMA-7.3 - Prostate Cancer, Recurrent Prostate Cancer
Phase 2Not yet recruitingWashington University School of Medicine202026-10-312026-09-11
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
PROSTEST - Prostate Cancer, Urology
RecruitingWren Laboratories LLC15002026-04-152026-08-21
RegisterPROS - A Registry for Prostate Cancers
PROSTest - Prostate Cancer (Adenocarcinoma), Prostate Biopsy
Enrolling by invitationWren Laboratories LLC10002020-01-152026-08-21

Conditions studied

Prostatic Neoplasms (3)  ·  Adenocarcinoma (1)  ·  Disease (1)

Sponsors

Wren Laboratories LLC (2)  ·  Washington University School of Medicine (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Abdel Halim, PhD, PharmD (1)  ·  Abdel Halim, PharmD, PhD (1)  ·  Kambiz Rahbar, MD (1)  ·  Vikas Prasad, MD, PhD (1)

Results publications

PMID 40640763